Sphingolipids modulate many aspects of cell function, including the express
ion of cytochrome P450, a superfamily of heme proteins that participate in
the oxidation of a wide range of compounds of both endogenous (steroid horm
ones and other lipids) and exogenous (e.g. alcohol, drugs and environmental
pollutants) origin. Cytochrome P450-2C11 (CYP 2C11) is down-regulated in r
esponse to interleukin-1 beta (IL-1 beta), and this response involves the h
ydrolysis of sphingomyelin to ceramide as well as ceramide to sphingosine,
and phosphorylation of sphingosine to sphingosine 1-phosphate. Activation o
f ceramidase(s) are a key determinant of which bioactive sphingolipid metab
olites are formed in response to IL-1 beta. Ceramidase activation also appe
ars to account for the loss of expression of CYP 2C11 when hepatocytes are
placed in cell culture, and the restoration of expression when they are pla
ted on Matrigel; hence, this pathway is influenced by, and may mediate, int
eractions between hepatocytes and the extracellular matrix. Recent studies
using inhibitors of sphingolipid metabolism have discovered that sphingolip
ids are also required for the induction of CYP 1A1 by 3-methylcholanthrene,
however, in this case, the requirement is for de novo sphingolipid biosynt
hesis rather than the turnover of complex sphingolipids. These findings ill
ustrate how changes in sphingolipid metabolism can influence the regulation
of at least several isoforms of cytochrome P450. (C) 1999 Elsevier Science
Ireland Ltd. All rights reserved.